CI:NYE-Cigna Corporation (USD)

EQUITY | Healthcare Plans | New York Stock Exchange

Last Closing

USD 339.98

Change

0.00 (0.00)%

Market Cap

USD 35.85B

Volume

4.08M

Analyst Target

USD 242.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Cigna Corp is a health services organization. The Company provides medical, dental, disability, life and accident insurance and related products and services.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-23 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

-1.50 (-0.26%)

USD 532.88B
ELV Elevance Health Inc

-0.21 (-0.04%)

USD 125.09B
CNC Centene Corp

-0.42 (-0.57%)

USD 39.78B
MOH Molina Healthcare Inc

-5.98 (-1.74%)

USD 20.81B
OSCR Oscar Health Inc

-1.10 (-5.10%)

USD 5.25B
NEUE NeueHealth Inc

+0.06 (+1.20%)

USD 0.05B
CVS CVS Health Corp

+0.37 (+0.63%)

N/A
HUM Humana Inc

+1.09 (+0.35%)

N/A

ETFs Containing CI

AILV 4.45 % 0.00 %

N/A

N/A
WBIL WBI BullBear Quality 3000.. 4.31 % 1.07 %

+0.24 (+0.20%)

USD 0.04B
KNGU:CA Brompton U.S. Cash Flow K.. 4.03 % 0.00 %

+0.02 (+0.20%)

CAD 4.99M
CBUF:XETRA iShares MSCI World Health.. 3.30 % 0.00 %

-0.01 (0.20%)

USD 1.13B
CBUF:F iShares V Public Limited .. 3.27 % 0.00 %

-0.01 (0.20%)

N/A
WHCS:SW iShares MSCI World Health.. 3.22 % 0.00 %

N/A

N/A
SHRY First Trust Bloomberg Sha.. 3.18 % 0.00 %

+0.07 (+0.20%)

USD 0.02B
NSCR Nuveen Sustainable Core E.. 2.52 % 0.00 %

+0.10 (+0.20%)

USD 5.49M
FSST Fidelity Sustainability U.. 2.50 % 0.00 %

+0.19 (+0.20%)

USD 0.01B
UVAL:LSE SPDR® MSCI USA Value UCI.. 2.46 % 0.00 %

-0.03 (0.20%)

USD 0.14B
USVL:LSE SPDR® MSCI USA Value UCI.. 2.46 % 0.00 %

+0.27 (+0.20%)

USD 0.14B
ZPRU:F SSgA SPDR ETFs Europe II .. 2.46 % 0.00 %

+0.16 (+0.20%)

USD 0.13B
ZPRU:XETRA SPDR® MSCI USA Value UCI.. 2.46 % 0.00 %

+0.09 (+0.20%)

USD 0.13B
UVAL:SW SPDR® MSCI USA Value UCI.. 2.46 % 0.00 %

+0.33 (+0.20%)

USD 0.14B
BUSA 2.38 % 0.00 %

N/A

N/A
FDWM Fidelity Covington Trust .. 1.76 % 0.00 %

+0.24 (+0.20%)

USD 3.99M
IQSA:XETRA Invesco Quantitative Stra.. 1.61 % 0.00 %

+0.34 (+0.20%)

USD 0.07B
IQSE:XETRA Invesco Quantitative Stra.. 1.61 % 0.00 %

+0.50 (+0.20%)

USD 0.05B
IQSA:LSE Invesco Quantitative Stra.. 1.54 % 0.00 %

+0.31 (+0.20%)

USD 0.49B
IQSA:F Invesco Markets II PLC - .. 1.53 % 0.00 %

+0.64 (+0.20%)

N/A
IQSE:F Invesco Markets II PLC - .. 1.53 % 0.00 %

+0.82 (+0.20%)

N/A
IS07:XETRA iShares Edge MSCI World M.. 1.47 % 0.00 %

+0.06 (+0.20%)

USD 0.01B
IFSW:SW iShares Edge MSCI World M.. 1.47 % 0.00 %

N/A

USD 0.57B
IBCZ:XETRA iShares Edge MSCI World M.. 1.44 % 0.00 %

+0.03 (+0.20%)

USD 0.40B
DMFC:SW iShares Edge MSCI World M.. 1.42 % 0.00 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

+0.17 (+0.20%)

USD 0.07B
FUM:CA 0.00 % 0.80 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

-0.03 (0.20%)

N/A
QSY 0.00 % 0.38 %

N/A

N/A
HONR 0.00 % 0.65 %

N/A

N/A
DSTL Distillate US Fundamental.. 0.00 % 0.00 %

+0.41 (+0.20%)

USD 2.05B
BUYB:LSE Invesco Global Buyback Ac.. 0.00 % 0.00 %

+0.38 (+0.20%)

N/A
RYH 0.00 % 0.40 %

N/A

N/A
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.40 %

+0.69 (+0.20%)

N/A
XXM:CA 0.00 % 0.68 %

N/A

N/A
XMWD:LSE Xtrackers MSCI World Swap.. 0.00 % 0.00 %

+0.60 (+0.20%)

N/A
TPHC:PA Amundi Index Solutions - .. 0.00 % 0.00 %

+2.45 (+0.20%)

USD 9.21M
TPXE:PA Amundi Index Solutions - .. 0.00 % 0.00 %

+2.20 (+0.20%)

USD 0.27B
TPXH:PA Amundi Index Solutions - .. 0.00 % 0.00 %

+9.52 (+0.20%)

USD 0.23B
IBCZ:F iShares IV Public Limited.. 0.00 % 0.00 %

+0.04 (+0.20%)

N/A
IS07:F iShares IV Public Limited.. 0.00 % 0.00 %

+0.07 (+0.20%)

N/A
TTPX:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

+9.57 (+0.20%)

USD 0.40B
VGVL:XETRA 0.00 % 0.00 %

N/A

N/A
VMUS:XETRA 0.00 % 0.00 %

N/A

N/A
HDIV 0.00 % 0.00 %

N/A

N/A
NTZG Nuveen Global Net Zero Tr.. 0.00 % 0.00 %

+0.28 (+0.20%)

USD 6.62M
BUYB:SW Invesco Global Buyback Ac.. 0.00 % 0.00 %

+0.11 (+0.20%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.53% 88% B+ 83% B
Dividend Return 0.94% 80% B- 34% F
Total Return 14.47% 88% B+ 82% B
Trailing 12 Months  
Capital Gain 23.70% 88% B+ 80% B-
Dividend Return 1.91% 80% B- 30% F
Total Return 25.61% 88% B+ 79% B-
Trailing 5 Years  
Capital Gain 112.38% 100% F 88% B+
Dividend Return 10.14% 50% F 39% F
Total Return 122.53% 100% F 88% B+
Average Annual (5 Year Horizon)  
Capital Gain 15.32% 63% D 80% B-
Dividend Return 16.67% 63% D 79% B-
Total Return 1.36% 60% D- 32% F
Risk Return Profile  
Volatility (Standard Deviation) 18.32% 88% B+ 56% F
Risk Adjusted Return 91.01% 75% C 97% N/A
Market Capitalization 35.85B 78% C+ 98% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Healthcare Plans) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 18.60 29% 26%
Price/Book Ratio 2.15 75% 40%
Price / Cash Flow Ratio 8.08 56% 46%
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity 8.97% 33% 53%
Return on Invested Capital 6.56% 56% 51%
Return on Assets 3.08% 33% 56%
Debt to Equity Ratio 60.91% 56% 54%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.